More on the cost issue

dLife Today: Penny Wise and Pound Foolish?

A recent UK decision highlights one of the problems with universal coverage, and interestingly enough, it isn’t that different from an issue faced by Americans under many managed care programs – cost pressures that deny life-enhancing drugs.

This definately bit me in the rear when I first went on an insulin pump. My diabetes care and my life has improved significantly since I started pumping insulin. However, the HMO I belonged to, wouldn’t fund it, and I did it out of pocket. I’ll probably have to do the CGMS system out of pocket too, I just have to decide if it is worth it.

Comments

2 responses to “More on the cost issue”

  1. Scott K. Johnson Avatar

    Hi Kathleen!
    This topic drives me nuts. These darn insurance companies are just convinced that they can avoid the even more expensive costs because we’ll probably be on someone elses plan down the road.
    Arg.
    I have a better chance of avoiding those costly complications if I can get what I need NOW!
    Anyway – just dropping a quick note to let you know I feel your pain! Very frustrating.

  2. Scott K. Johnson Avatar

    Hi Kathleen!
    This topic drives me nuts. These darn insurance companies are just convinced that they can avoid the even more expensive costs because we’ll probably be on someone elses plan down the road.
    Arg.
    I have a better chance of avoiding those costly complications if I can get what I need NOW!
    Anyway – just dropping a quick note to let you know I feel your pain! Very frustrating.

Leave a Reply

Your email address will not be published. Required fields are marked *